Mitochondrial biology and neurological diseases

S Arun, L Liu, G Donmez - Current neuropharmacology, 2016 - ingentaconnect.com
Mitochondria are extremely active organelles that perform a variety of roles in the cell
including energy production, regulation of calcium homeostasis, apoptosis, and population …

Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through

AS Jusop, K Thanaskody, GJ Tye, SA Dass… - Frontiers in Molecular …, 2023 - frontiersin.org
Neurodegenerative diseases are adult-onset neurological conditions that are notoriously
difficult to model for drug discovery and development because most models are unable to …

Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions

S Kumar, S Mehan, AS Narula - Journal of Molecular Medicine, 2023 - Springer
The cytokine-activated Janus kinase (JAK)–signal transducer and activator of transcription
(STAT) cascade is a pleiotropic pathway that involves receptor subunit multimerization. The …

Effect of flavonoids rich extract of Capparis spinosa on inflammatory involved genes in amyloid-beta peptide injected rat model of Alzheimer's disease

N Mohebali, SA Shahzadeh Fazeli… - Nutritional …, 2018 - Taylor & Francis
Objectives: Alzheimer's disease (AD) is one of the most common forms of
neurodegenerative diseases. Despite vast ongoing researches focusing on the area, little is …

Repressor element-1 binding transcription factor (REST) as a possible epigenetic regulator of neurodegeneration and MicroRNA-based therapeutic strategies

A Nassar, S Satarker, PC Gurram, D Upadhya… - Molecular …, 2023 - Springer
Neurodegenerative disorders (NDD) have grabbed significant scientific consideration due to
their fast increase in prevalence worldwide. The specific pathophysiology of the disease and …

Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease

I Mumtaz, MO Ayaz, MS Khan, U Manzoor… - Frontiers in Aging …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disorder that causes progressive loss of
cognitive functions like thinking, memory, reasoning, behavioral abilities, and social skills …

Identification of a novel Wnt antagonist based therapeutic and diagnostic target for Alzheimer's disease using a stem cell-derived model

M Patil, N Gamit, A Dharmarajan, G Sethi, S Warrier - Bioengineering, 2023 - mdpi.com
Currently, all the existing treatments for Alzheimer's disease (AD) fail to stall progression due
to longer duration of time between onset of the symptoms and diagnosis of the disease …

Changes in Expression of Key Genes in Alzheimer's Disease: A Specific Brain Tissue Change

LT Rasmussen, RW de Labio… - The Journals of …, 2024 - academic.oup.com
Alzheimer's disease (AD) is an irreversible and neurodegenerative disorder. Its etiology is
not clear, but the involvement of genetic components plays a central role in the onset of the …

Oxidative stress and aberrant cell cycle in Alzheimer's disease lymphocytes: diagnostic prospects

J Wojsiat, C Prandelli… - Journal of …, 2015 - content.iospress.com
In Alzheimer's disease (AD), molecular changes are observed not only in patients' neurons
but also in peripheral cells, such as blood lymphocytes. These include changes in the level …

Metals toxicity and its correlation with the gene expression in Alzheimer's disease

J Yadav, AK Verma, MK Ahmad, RK Garg, Shiuli… - Molecular Biology …, 2021 - Springer
Alzheimer's disease is a common neurodegenerative disease in the elderly population and
a leading cause of dementia. Genetics and environmental risk factors were considered to …